Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy.

Journal of cancer research and clinical oncology - 1 Apr 2000

Junker K, Wiethege T, Müller K M, Thomas M

Abstract excerpt

In a phase II study for optimizing therapeutic management of locally advanced non-small-cell lung cancer the prognostic and therapeutic relevance of the p53 status was investigated. Biopsy or mediastinoscopy samples, collected prior to neoadjuvant chemoradiotherapy and corresponding resection specimens, were analysed immunohistochemically (CM1 antiserum) for p53 accumulation and molecular biologically (polymerase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Neoadjuvant Therapy

Share to Outcome Assessment, Health Care

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10782898
DOI: 10.1007/s004320050039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy.PMID 10782898Read ↗

Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer.Semantic proximity Read ↗

Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry.Semantic proximity Read ↗

p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival.Semantic proximity Read ↗

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.Semantic proximity Read ↗

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.Semantic proximity Read ↗

[Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer].Semantic proximity Read ↗

p53 expression in non small cell lung cancer: clinical and biological correlations.Semantic proximity Read ↗

p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland.Semantic proximity Read ↗

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.Semantic proximity Read ↗

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.Semantic proximity Read ↗

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.Semantic proximity Read ↗

[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.